TrialThe Journal of clinical endocrinology and metabolism2026
Exenatide induces an enhanced endogenous glucagon-like peptide-1 secretory response in patients receiving basal insulin.
Mihir Parikh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.